Stringer, Frances <br/><br/>
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent.  [electronic resource] 

 -  European journal of clinical pharmacology  Mar 2013 
 - 423-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-012-1382-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Analysis of Variance<br/>Area Under Curve<br/>Biotransformation<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Female<br/>Glucuronosyltransferase--genetics<br/>Half-Life<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Pharmacogenetics<br/>Phenotype<br/>Polymorphism, Genetic<br/>Propionates--administration & dosage<br/>Thiazoles--administration & dosage<br/>United Kingdom<br/>Young Adult